These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2033431)

  • 21. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
    Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH; Meyers PA
    J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and Marrow Transplant Consortium.
    Kletzel M; Abella EM; Sandler ES; Williams LL; Ogden AK; Pollock BH; Wall DA
    J Pediatr Hematol Oncol; 1998; 20(1):49-54. PubMed ID: 9482413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results.
    Matthay KK; O'Leary MC; Ramsay NK; Villablanca J; Reynolds CP; Atkinson JB; Haase GM; Stram DO; Seeger RC
    Eur J Cancer; 1995; 31A(4):572-5. PubMed ID: 7576971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
    Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation.
    Saarinen UM; Wikström S; Mäkipernaa A; Lanning M; Perkkiö M; Hovi L; Rapola J; Sariola H
    J Clin Oncol; 1996 Oct; 14(10):2791-802. PubMed ID: 8874341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
    Martino M; Postorino M; Gallo GA; Messina G; Neri S; Piro E; Gentile M; Moscato T; Monteleone R; Fedele R; Mazzone C; Console G; Penna G; Alati C; Vincelli ID; Irrera G; Musolino C; Ronco F; Molica S; Morabito F
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):148-54. PubMed ID: 24417912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II study.
    Pinkerton CR; Philip T; Biron P; Frapazz D; Phillipe N; Zucker JM; Bernard JL; Philip I; Kemshead J; Favrot M
    Med Pediatr Oncol; 1987; 15(5):236-40. PubMed ID: 3309605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of neuroblastoma: role of total body irradiation].
    Franzone P; Corvò R; Dini G; Perin GP; Scarpati D
    Radiol Med; 1986 Dec; 72(12):959-62. PubMed ID: 3541069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma.
    De Bernardi B; Carli M; Casale F; Corciulo P; Cordero di Montezemolo L; De Laurentis C; Bagnulo S; Brisigotti M; Marchese N; Garaventa A
    J Clin Oncol; 1992 Dec; 10(12):1870-8. PubMed ID: 1453202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.
    Brice P; Gisselbrecht C; Ferme C; Lepage E; Baruchel A; Marolleau JP; Gerota O; Boiron M
    Nouv Rev Fr Hematol (1978); 1991; 33(3):267-72. PubMed ID: 1956765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
    Matthay KK; Villablanca JG; Seeger RC; Stram DO; Harris RE; Ramsay NK; Swift P; Shimada H; Black CT; Brodeur GM; Gerbing RB; Reynolds CP
    N Engl J Med; 1999 Oct; 341(16):1165-73. PubMed ID: 10519894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unpurged ABMT for neuroblastoma: AIEOP-BMT experience.
    Dini G; Lanino E; Garaventa A; Paolucci P; Amici A; Locatelli F; Colleselli P; Boni L; Dallorso S; Abla O
    Bone Marrow Transplant; 1991; 7 Suppl 2():92. PubMed ID: 1878740
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children].
    Ortega Aramburu JJ; Olivé Oliveras T; Javier Manchón G; Bastida Vila P; Sánchez C; Giralt López J
    Sangre (Barc); 1991 Feb; 36(1):7-14. PubMed ID: 1853274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous bone marrow transplantation for pediatric Wilms' tumor: the experience of the European Bone Marrow Transplantation Solid Tumor Registry.
    Garaventa A; Hartmann O; Bernard JL; Zucker JM; Pardo N; Castel V; Dallorso S; Adelbost Z; Ladenstein R; Chauvin F
    Med Pediatr Oncol; 1994; 22(1):11-4. PubMed ID: 8232074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
    Verdonck LF; Dekker AW; de Gast GC; van Kempen ML; Lokhorst HM; Nieuwenhuis HK
    J Clin Oncol; 1992 Dec; 10(12):1949-54. PubMed ID: 1453209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single institution experience with high-dose cyclophosphamide, continuous infusion vincristine, escalating doses of VP-16-213, and total body irradiation with unpurged bone marrow rescue in children with neuroblastoma.
    Kletzel M; Becton DL; Berry DH
    Med Pediatr Oncol; 1992; 20(1):64-7. PubMed ID: 1530757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
    Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
    Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.
    Williams CD; Pearce R; Taghipour G; Green ES; Philip T; Goldstone AH
    J Clin Oncol; 1994 Nov; 12(11):2415-22. PubMed ID: 7964958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.